Osteoporosis International

, Volume 17, Issue 7, pp 1086–1095 | Cite as

Biochemical markers of bone turnover predict bone loss in perimenopausal women but not in postmenopausal women-the Japanese Population-based Osteoporosis (JPOS) Cohort Study

  • M. Iki
  • A. Morita
  • Y. Ikeda
  • Y. Sato
  • T. Akiba
  • T. Matsumoto
  • H. Nishino
  • S. Kagamimori
  • Y. Kagawa
  • H. Yoneshima ·
  • For the JPOS Study Group
Original Article



The predictive value of biochemical markers of bone turnover for subsequent change in bone density in a population sample of healthy women with a wide range of ages has not been fully established.


We followed 1,283 women aged 15–79 years at baseline selected randomly from the inhabitants of three areas in Japan for 6 years, and examined 1,130 subjects with no disease or administration of drugs affecting bone metabolism. The annual change in bone density at the spine, total hip, and distal one third of the radius was determined during the follow-up period by dual x-ray absorptiometry and was compared among the groups using different levels of biochemical markers at baseline, including serum osteocalcin (OC) and bone-specific alkaline phosphatase (bone ALP), free and total (tDPD) forms of immunoreactive deoxypyridinoline, and type I collagen crosslinked C-terminal telopeptide (CTX) in urine.


Premenopausal women aged 45 years or older with elevated levels of OC, bone ALP, CTX, or tDPD showed significantly greater bone loss at most skeletal sites during the follow-up period than those with lower levels, after adjustment for the effects of age, height, weight, dietary calcium intake, regular exercise, and current smoking. The greatest coefficient of determination of the model was observed in the association between CTX and bone loss at the hip during the first 3 years of follow-up (42.8%). These subjects were pooled with perimenopausal women at baseline, and those who still menstruated at follow-up in this pooled group showed significant but more modest associations, whereas those who entered menopause during the follow-up period showed clear associations. However, early postmenopausal women with less than 5 or 10 years since menopause showed an association that was limited mostly to the distal radius, and other postmenopausal groups had virtually no association.


Biochemical markers of bone turnover may predict bone loss in women undergoing menopausal transition but may not predict bone loss in postmenopausal women.


Bone mineral density Bone turnover markers Japanese women Longitudinal study Population-based epidemiologic study Random sample 



This study was conducted by the JPOS Study Group, comprising Fumiaki Marumo (Chairman of the Study Group, Professor Emeritus, Tokyo Medical and Dental University), Toshihisa Matsuzaki (Co-chairman of the Study Group, Institute of Comprehensive Community Care), Etsuko Kajita (Nagoya University School of Health Sciences), Tomoharu Matsukura (Kanazawa University), and Takashi Yamagami (Hokuriku Health Service Association), along with the authors. Financial support for the baseline survey was provided by the Japan Milk Promotion Board and the Japan Dairy Council. The follow-up surveys were financially supported by a Grant-in-aid for Scientific Research (B #10470114, 1998–2000, and B #1437017, 2002–2003) from the Japanese Society for the Promotion of Science and a grant in 2000–2002 from the Research Society for Metabolic Bone Diseases, Japan. The authors wish to express special thanks to the personnel of the health departments of Hirara City, Sanuki City, and Nishi-Aizu Town for their excellent support of the study, and to those from SRL, Tokyo, Japan; Toyo Medic, Osaka, Japan; and Toyukai Medical Corporation, Tokyo, Japan, for their technical assistance with the surveys.


  1. 1.
    Christiansen C, Riis BJ, Rodbro P (1987) Prediction of rapid bone loss in postmenopausal women. Lancet 1:1105–1108PubMedCrossRefGoogle Scholar
  2. 2.
    Christiansen C, Riis BJ, Rodbro P (1990) Screening procedure for women at risk of developing postmenopausal osteoporosis. Osteoporos Int 1:35–40PubMedCrossRefGoogle Scholar
  3. 3.
    Slemenda C, Hui SL, Longcopy C, Johnston CC (1987) Sex steroids and bone mass: a study of change about the time of menopause. J Clin Invest 80:1261–1269PubMedCrossRefGoogle Scholar
  4. 4.
    Johansen JS, Riis BJ, Delmas PD, Christiansen C (1988) Plasma BGP: an indicator of spontaneous bone loss and of the effect of oestrogen treatment in postmenopausal women. Eur J Clin Invest 18:191–195PubMedGoogle Scholar
  5. 5.
    Uebelhart D, Schlemmer A, Johansen JS, Gineyts E, Christiansen C, Delmas PD (1991) Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links. J Clin Endocrinol Metab 72:367–373PubMedCrossRefGoogle Scholar
  6. 6.
    Slemenda C, Longcope C, Peacock M, Hui S, Johnston CC (1996) Sex steroids, bone mass and bone loss: a prospective study of pre-, peri-, and postmenopausal women. J Clin Invest 97:14–21PubMedGoogle Scholar
  7. 7.
    Garnero P, Sornay-rendu E, Duboeuf F, Delmas PD (1999) Markers of bone turnover predict postmenopausal forearm bone loss over 4 years: the OFELY study. J Bone Miner Res 14:1614–1621PubMedCrossRefGoogle Scholar
  8. 8.
    Cosman F, Nieves J, Wilkinson C, Schnering D, Shen V, Lindsay R (1996) Bone density change and biochemical indices of skeletal turnover. Cacif Tis Int 58:236–243Google Scholar
  9. 9.
    Iki M, Kajita E, Dohi Y, Nishino H, Kusaka Y Tsuchida C, Yamamoto K, Ishii Y (1996) Age, menopause, bone turnover markers and lumbar bone loss in healthy Japanese women. Maturitas 25:59–67PubMedCrossRefGoogle Scholar
  10. 10.
    Marcus R, Holloway L, Wells B, Greendale G, James MK, Wasilauskas C, Kelaghan J (1999) The relationship of biochemical markers of bone turnover to bone density changes in postmenopausal women: results from the postmenopausal estrogen/progestin interventions (PEPI) trial. J Bone Miner Res 14:1583–1595PubMedCrossRefGoogle Scholar
  11. 11.
    Roggers A, Hannon RA, Eastell R (2000) Biochemical markers as predictors of rates of bone loss after menopause. J Bone Miner Re 15:1398–1404CrossRefGoogle Scholar
  12. 12.
    Chaki, O, Yoshikata I, Kikuchi R, Nakayama M, Uchiyama Y, Hirahara F, Gorai I (2000) The predictive value of biochemical markers of bone turnover for bone mineral density in postmenopausal Japanese women. J Bone Miner Res 15:1537–1544PubMedCrossRefGoogle Scholar
  13. 13.
    Chapurlat RD, Garnero P, Sorney-Rendu E, Arlot ME, Claustrat B, Delmas PD (2000) Longitudinal study of bone loss in pre- and perimenopausal women: evidence for bone loss in perimenopausal women. Osteoporos Int 11:493–498PubMedCrossRefGoogle Scholar
  14. 14.
    Dennison E, Eastel R, Fall CHD, Kellingray S, Wood PJ, Cooper C (1999) Determinants of bone loss in elderly men and women: a prospective population-based study. Osteoporos Int 10:384–391PubMedCrossRefGoogle Scholar
  15. 15.
    Melton LJ 3rd, Atkinson EJ, O’Connor MK, O’Fallon WM, Riggs BL (2000) Determinants of bone loss from the femoral neck in women of different ages. J Bone Miner Res 15:24–31PubMedCrossRefGoogle Scholar
  16. 16.
    Delmas PD, Estell R, Garnero P, Seibel MJ, Stapan J (2000) A position paper on the use of biochemical markers of bone turnover in osteoporosis. Osteoporos Int 11(Suppl 6):S2–S17PubMedCrossRefGoogle Scholar
  17. 17.
    Stepan JJ (2000) Prediction of bone loss in postmenopausal women. Osteoporos Int 11(Suppl 6):S45–S54PubMedCrossRefGoogle Scholar
  18. 18.
    Iki M, Kagamimori S, Kagawa Y, Matsuzaki T, Yoneshima H, Marumo F (2001) Bone mineral density of the spine, hip and distal forearm in representative samples of the Japanese female population: Japanese Population-Based Osteoporosis (JPOS) Study. Osteoporos Int 12:529–537PubMedCrossRefGoogle Scholar
  19. 19.
    Iki M, Akiba T, Matsumoto T, Nishino H, Kagamimori S, Kagawa Y, Yoneshima H (2004) Reference database of biochemical markers of bone turnover for the Japanese female population. Japanese Population-Based Osteoporosis (JPOS) Study. Osteoporos Int 15:981–991PubMedCrossRefGoogle Scholar
  20. 20.
    Kawaguchi H, Matsumoto T, Kurokawa T, Orimo H, Mizunashi K, Takuwa Y, Niimi H, Shiraki M, Ohara T, Shishiba Y, Tsuchiya Y, Takahshi H, Takatsuki K, Seino Y, Morii H, Fujita T, Okamoto S, Ogata E (1990) Serum levels of BGP determined by two-site immunoradiometric assay (IRMA) using monoclonal antibodies. Clin Endocrinol 38:1291–1296 (in Japanese)Google Scholar
  21. 21.
    Garnero P, Delmas PD (1993) Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease. J Clin Endocrinol Metab 77:1046–1053PubMedCrossRefGoogle Scholar
  22. 22.
    Bonde M, Qvist P, Fledelius C, Riis BJ, Christiansen C (1994) Immunoassay for quantifying type I collagen degradation products in urine evaluated. Clin Chem 40:2022–2025PubMedGoogle Scholar
  23. 23.
    Robins SP, Woitge H, Hesley R, Ju J, Seyedin S, Seibel MJ (1994) Direct enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption. J Bone Miner Res 9:1643–1649PubMedGoogle Scholar
  24. 24.
    Nussbaum SR, Zahradnik RJ, Lavigne JR, Brennan GL, Nozawa-Ung K, Kim LY, Keutmann HT, Wang CA, Potts JT jr, Segre GV (1987) Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Clin Chem 33:1364–1367PubMedGoogle Scholar
  25. 25.
    Suzumura E, Watanabe Y, Suzuki T, Yonezawa M, Yamauchi S, Ishigami T, Takezawa J, Ichikawa M, Seino Y (1992) Study of 1,25(OH)2D RPA kit using bovine mammary gland receptor and non-HPLC purification. Clin Endocrinol 40:1211–1218 (in Japanese)Google Scholar
  26. 26.
    McCloskey EV, Spector TD, Eyres KS, Fern ED, O’Rourke N, Vasikaran S, Kanis JA (1993) The assessment of vertebral deformity: a method for use in population studies and clinical trials. Osteoporos Int 3:138–147PubMedCrossRefGoogle Scholar
  27. 27.
    Nathan H (1962) Osteophytes of the vertebral column. J Bone Joint Surg 44-A:243–269Google Scholar
  28. 28.
    Sato Y, Tamaki J, Kitayama F, Kusaka Y, Kodera Y, Koutani A, Iki M (2005) Development of a food-frequency questionnaire to measure the dietary calcium intake of adult Japanese women. Tohoku J Exp Med 207:217–222PubMedCrossRefGoogle Scholar
  29. 29.
    Garnero P, Hausher E, Chapuy MC, Marcelli C, Grandjean H, Muller C, Cormier C, Breart G, Meunier PG, Delmas PD (1996) Markers of bone resorption predict hip fracture in elderly women: the Eidos prospective study. J Bone Miner Res 11:1531–1538PubMedCrossRefGoogle Scholar
  30. 30.
    Garnero P, Sornay-Rendu E, Claustrat B, Delmas PD (2000) Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the Ofely study. J Bone Miner Res 15:1526–1536PubMedCrossRefGoogle Scholar
  31. 31.
    Ross PD, Kress BC, Parson RE, Wasnich RD, Armour KA, Mizrahi IA (2000) Serum bone alkaline phosphatase and calcaneus bone density predict fractures: a prospective study. Osteoporos Int 11:76–82PubMedCrossRefGoogle Scholar
  32. 32.
    Luukinen H, Käkönen SM, Pettersson K, Koski K, Laippala P, Lövgren T, Kivelä SL, Väänänen HK (2000) Strong prediction of fractures among older adults by the ratio of carboxylated to total serum osteocalcin. J Bone Miner Res 15:2473–2478PubMedCrossRefGoogle Scholar
  33. 33.
    Riis BJ, Hansen MA, Jensen AM, Overgaard K, Christiansen C (1996) Low bone mass and fast rate of bone loss at menopause: equal risk factors for future fracture: a 15-year follow-up study. Bone 19:9–12PubMedCrossRefGoogle Scholar
  34. 34.
    Komukai S, Ohta H, Makita K, Yanamoto S, Takamatsu K, Okano H, Yajima M, Nozawa S (2003) One-year spinal bone change in pre- and perimenopausal Japanese women. Hormone Res 59:79–84PubMedCrossRefGoogle Scholar
  35. 35.
    Picard D, Imback A, Couturier R, Lepage R, Ste-Marie LG (2000) Longitudinal study of bone density and its determinants in women in peri or early menopause. Calcif Tissue Int 67:356–360PubMedCrossRefGoogle Scholar
  36. 36.
    Bastian LA, Smith CM, Nanda K (2003) Is this woman perimenopausal? JAMA 289:895–902PubMedCrossRefGoogle Scholar
  37. 37.
    Arslan AA, Zeleniuch-Jacquotte A, Lukanova A, Rinaldi S, Kaaks R, Toniolo P (2003) Reliability of follicle-stimulating hormone measurements in serum. Reprod Biol Endocrinol 1:49PubMedCrossRefGoogle Scholar

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2006

Authors and Affiliations

  • M. Iki
    • 1
  • A. Morita
    • 1
  • Y. Ikeda
    • 1
  • Y. Sato
    • 2
  • T. Akiba
    • 3
  • T. Matsumoto
    • 4
  • H. Nishino
    • 5
  • S. Kagamimori
    • 6
  • Y. Kagawa
    • 7
  • H. Yoneshima ·
    • 8
  • For the JPOS Study Group
  1. 1.Department of Public HealthKinki University School of MedicineOsaka-SayamaJapan
  2. 2.Department of Nutrition, School of Nutrition and NursingTenshi CollegeSapporoJapan
  3. 3.Department of Blood Purification and Internal Medicine, Kidney CenterTokyo Women’s Medical UniversityTokyoJapan
  4. 4.Department of Medicine and Bioregulatory SciencesUniversity of Tokushima Graduate School of Health BiosciencesTokushimaJapan
  5. 5.Toyama Red Cross Blood CenterToyamaJapan
  6. 6.Department of Welfare Promotion and EpidemiologyFaculty of Medicine, University of ToyamaToyamaJapan
  7. 7.Kagawa Nutrition UniversityTokyoJapan
  8. 8.Shuuwa General HospitalKasukabeJapan

Personalised recommendations